Carter Worth of Cornerstone Macro spoke on CNBC's "Fast Money," about stocks that could outperform in the second half of the year.
iShares NASDAQ Biotechnology Index IBB has been trading sideways for the last three years and it is finally breaking out on the upside. He expects it to continue to move higher.
iShares Silver Trust SLV could trade much higher, said Worth. He noticed a rounding bottom technical pattern on its charts and he wants to buy it.
Thermo Fisher Scientific Inc. TMO and Danaher Corporation DHR have outperformed both SPDR S&P 500 ETF Trust SPY and PowerShares QQQ Trust QQQ over a five-year period. They are not overdone because they have a lower beta than the market, explained Worth.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.